Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H41NO6 |
| Molecular Weight | 475.6175 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C
InChI
InChIKey=FWFVLWGEFDIZMJ-FOMYWIRZSA-N
InChI=1S/C27H41NO6/c1-5-28(6-2)15-23(32)34-16-22(31)27(33)12-10-20-19-8-7-17-13-18(29)9-11-25(17,3)24(19)21(30)14-26(20,27)4/h13,19-21,24,30,33H,5-12,14-16H2,1-4H3/t19-,20-,21-,24+,25-,26-,27-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/5881687
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5881687
Hydrocortamate is a synthetic glucocorticoid possessing anti-inflammatory properties and acting as a glucocorticoid receptor agonist. Hydrocortamate was used under the brand name Magnacor to treat inflammation due to corticosteroid-responsive dermatoses btut that usage has been discontinued.
Approval Year
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/20637097/ Page: - |
yes |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5881687
Unknown
Route of Administration:
Irrigation
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB08064MIG
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
686
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
200-963-9
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
Y3N00BK5WK
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
DTXSID1057824
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
100000084195
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
Hydrocortamate
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
m1187
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | Merck Index | ||
|
50851
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
DB00769
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
84088
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
C65862
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
76-47-1
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
1387
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201263
Created by
admin on Mon Mar 31 18:29:05 GMT 2025 , Edited by admin on Mon Mar 31 18:29:05 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)